Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Concept Study for Evaluation of the Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache

NCT04179266 is registered in ClinicalTrials.gov with CCH Pharmaceuticals as lead sponsor.

NCT NCT04179266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04179266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Concept Study for Evaluation of the Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache
Lead sponsor
CCH Pharmaceuticals
Phase
Phase 1/2
Overall status
Completed
Start date
November 20, 2019
Completion date
May 25, 2020
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cluster headache